Directories

Advertisement

Furiex Pharmaceuticals, Inc.

Address:
City:
Province:
ZIP Code:
Country:

Furiex Acquires Full Exclusive License To MuDelta For The Treatment Of Diarrhea-Predominant IBS and Reports Positive End Of Phase II FDA Meeting

2011-11-02

MORRISVILLE, N.C. ---- Furiex Pharmaceuticals, Inc. (Nasdaq: FURX) announced today that it has acquired full exclusive license rights to develop and commercialize the compound MuDelta under its existing development and license agreement with Janssen Pharmaceutica N.V. Furiex acquired these rights as a result of Janssen’s decision, after an evaluation of strategic fit within its late stage portfolio, not to exercise its option under the agreement to continue development of MuDelta. Furiex will owe payments......

Company Info    More Info